New Tools to Diagnose Superbugs Called for at World Economic Forum
January 30th 2017The Joint United Nations Programme on HIV/AIDS and medical technology industry partners have announced new efforts to better diagnose bacterial infections at the recent World Economic Forum Annual Meeting in Davos, Switzerland.
Too Many Conflicts of Interest Found in HCV Management Guidelines
January 29th 2017A group of researchers recently published a study in JAMA, examining conflicts of interest (COIs) among committee members who set hepatitis C (HCV) and cholesterol management guidelines. They found that there, in fact, were COIs among committee members setting HCV management guidelines.
Cost-Effectiveness of Preferred Antibiotics for Community-Acquired Pneumonia
January 24th 2017Researchers from the Julius Center for Health Sciences and Primary Care at the University Medical Center in Utrecht, The Netherlands, examine the cost-effectiveness of the most commonly used treatments for community-acquired pneumonia.
HCV Treatment Achieves Viral Suppression in Less Than 12 Weeks
January 24th 2017Researchers conducted a post hoc analysis to learn whether or not the length of time it took to attain initial viral suppression is related to sustained virologic response (SVR) rates for patients receiving the so-call 3D treatment, with or without ribavirin.
Exploring the FDA's Tropical Disease Priority Review Voucher
January 23rd 2017As concerns over the spread of tropical infectious diseases increase, in the age of Zika virus and Dengue fever in particular, PRVs may have significant implications for the development of novel vaccines and antivirals, assuming the program is used effectively.